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Abstract
Background: Metabolic plasticity and the versatility of different lineages of stem cells as they satisfy their energy
demands are not completely understood. In this study we investigated the metabolic changes in mesenchymal
stem cells (MSCs) undergoing differentiation in two directions, osteogenic and chondrogenic, using two-photon
fluorescence microscopy combined with FLIM.
Methods: Differentiation was induced by incubating the human bone marrow MSCs in osteogenic or chondrogenic
mediums. Cellular metabolism was examined on the basis of the fluorescence of the metabolic cofactors NAD(P)H and
FAD. The optical redox ratio (FAD/NAD(P)H) and the fluorescence lifetimes of NAD(P)H and FAD were traced using
two-photon fluorescence microscopy combined with FLIM. The cells were imaged before the induction of
differentiation (day 0) and on days 7, 14, and 21 of osteogenic and chondrogenic differentiation.
Results: Based on the data for the FAD/NAD(P)H redox ratio and on the fluorescence lifetimes of protein-bound
NAD(P)H, we registered a metabolic shift toward a more glycolytic status in the process of MSC differentiation. The
difference was that, in osteogenic differentiation, an increase in oxidative phosphorylation preceded the shift to the
glycolytic status in the process of such MSC differentiation. The fluorescence lifetime characteristics of FAD indicated
the stimulation of an unknown metabolic pathway, where protein-bound FAD participates.
Conclusions: In this study, probing of the metabolic status of MSCs during osteogenic and chondrogenic differentiation
was implemented for the first time with the use of optical metabolic imaging of the two cofactors - NAD(P)H and FAD.
Our data suggest that biosynthetic processes, associated, presumably, with the synthesis of collagen, drive energy
metabolism in differentiating cells, and promote a metabolic shift from a more oxidative to a more glycolytic state.
Keywords: Mesenchymal stem cells, NAD(P)H, FAD, Osteogenic and chondrogenic differentiation, Metabolic shift,
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Background
Fluorescence lifetime imaging microscopy (FLIM) is
widely used in biomedical science as it offers non-invasive,
real-time measurements, optical sectioning capability with
high photon efficiency, high lifetime accuracy, and simul-
taneous recording at several wavelength intervals. FLIM
images represent a spatial distribution through the fluor-
escence decay profiles in every pixel. Several fluorescence
detection methods are available for lifetime measure-
ments, of which, time-correlated single photon counting
(TCSPC) enables simple data collection and enhanced
quantitative photon counting. The frequency domain
method involves sinusoidal modulation of the incident
light at high frequencies. In this method, the emission
occurs at the same frequency as the incident light, but
accompanied by a phase delay and a change in the ampli-
tude relative to the excitation light (demodulation) [1].
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Among FLIM applications, the imaging of endogenous
fluorophores, such as nicotinamide adenine dinucleotide
(NAD(P)H) and flavin adenine dinucleotide (FAD) has
undeniable value for metabolic studies because it does
not require any specific labeling [2]. Importantly, these
coenzymes are naturally fluorescent and, therefore,
genuine, non-invasive imaging of metabolic activities can
be carried out in living cells and tissues [3].
As the fluorescence lifetime of a fluorophore depends
on its molecular environment but not on its concentra-
tion, FLIM of NAD(P)H and FAD allows us to distinguish
between the free and protein-bound forms of the cofactors
[4, 5]. The short and long lifetime components in
NAD(P)H fluorescence decay are associated with free and
protein-bound states, respectively. FAD has both short
and long lifetime components, depending, respectively, on
whether it is protein-bound or free [6, 7].
NAD(P)H and FAD are major indicators of the em-
phasis of cellular metabolism. NADH and its oxidized
form (NAD+) are involved in mitochondrial function, en-
ergy metabolism, calcium homeostasis, gene expression,
oxidative stress, aging, and apoptosis. NAD+(NADH)
drives adenosine triphosphate (ATP) production in the
cytosol by glycolysis, and in the mitochondria by oxidative
phosphorylation. The reduced phosphorylated form,
NADPH, is involved in the reductive biosynthesis of fatty
acids and steroids, antioxidation and oxidative stress,
while the oxidized form, NADP+, participates in calcium
homeostasis [8].
Although FAD-containing proteins participate in a var-
iety of metabolic pathways including electron transport,
DNA repair, nucleotide biosynthesis, the beta-oxidation
of fatty acids, and amino acid catabolism, as well as the
synthesis of other cofactors such as coenzyme A (CoA),
coenzyme Q (CoQ) and heme groups, FAD is largely
associated with mitochondria and the oxidative phos-
phorylation pathway [3, 9]. Succinate dehydrogenase
(complex II in the electron transport chain) requires co-
valently bound FAD to catalyze the oxidation of succin-
ate to fumarate by coupling it with the reduction of
ubiquinone to ubiquinol. The high-energy electrons
from this oxidation are stored momentarily by reducing
FAD to FADH2. The FADH2 then reverts to FAD, send-
ing its two electrons through the electron transport
chain. Some data suggest that the majority of flavin
fluorescence is produced by lipoamide dehydrogenase
(LipDH)-containing enzyme complexes, such as the
pyruvate dehydrogenase complex (PDHC) and the
alpha-ketoglutarate dehydrogenase complex.
NAD(P)H and FAD are critical for a broad array of
oxidation–reduction (redox) reactions in living cells.
The ratio of the intensities of their fluorescence, referred
to as their “redox ratio”, is also a useful tool for real-
time monitoring of the metabolic state of a cell [10].
Although this ratio is not a direct measure of the
concentrations of these fluorophores, the fluorescence in-
tensity is a relative measure of their concentrations [3].
In stem cell biology the role of cellular metabolism
and macromolecular synthesis during differentiation has
not been fully studied. Many types of stem cell rely on
glycolysis for energy when undifferentiated, and then ac-
tivate the mitochondrial process of oxidative phosphor-
ylation (OxPhos) during differentiation [11]. The switch
of energy source from glycolysis to aerobic metabolism
is a hallmark of such differentiated cells [12]. However,
several studies demonstrate that not all differentiations
of stem cells are accompanied by an obvious metabolic
shift [13, 14]. So the metabolic plasticity and the versatil-
ity of different lineages of stem cells as they satisfy their
energy demands require further clarifications.
The current work was aimed at monitoring the metabolic
changes in mesenchymal stem cells (MSCs) undergoing
differentiation in two directions, osteogenic and chondro-
genic. Cellular metabolism was examined on the basis of
the fluorescence of the metabolic cofactors NAD(P)H and
FAD. The optical redox ratio (FAD/NAD(P)H) and the
fluorescence lifetimes of NAD(P)H and FAD were traced
using two-photon fluorescence microscopy combined with
FLIM.
Methods
Stem cell culture, osteogenic and chondrogenic
differentiation
Human bone marrow MSCs were isolated from the bone
marrow of normal donors, with their informed consent ac-
cording to the institutional guidelines under the approved
protocol. The MSCs were isolated as described previously
[15]. MSCs were immunophenotypically characterized by
flow cytometry on the Cell Lab Quanta SC (Beckman
Coulter, Brea, CA, USA). The common markers to human
MSCs (CD34, CD45, HLA-DR, CD105, CD44, CD54,
CD73, CD90) were studied [15].
The MSCs were cultured in MesenCult™ MSC Basal
Medium (Human) (Stemcell Technologies, Vancouver,
BC, Canada) supplemented with 10% fetal bovine serum
(FBS) (GE Healthcare Hyclone, Logan, UT, USA),
0.58 mg/ml L-glutamine (PanEco, Moscow, Russia) and
40 U/ml gentamicin. The cell culture was maintained at
37 °C in a 5% CO2, humidified atmosphere.
Differentiation was induced by incubating the MSCs
in MesenCult™ Osteogenic Stimulatory Kit (Human)
(Stemcell Technologies) or Stem MACS™ Chondro Diff
Media (MASC, Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany). The medium was replaced every 3–4 days over
the experimental period of up to 4 weeks.
Morphological changes were assessed by counting the
number of cells with spindle-shaped and polygonal
morphology at each differentiation stage. Osteogenic
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and chondrogenic differentiations were verified by stain-
ing calcifications of the extracellular matrix with Alizarin
Red S (Sigma-Aldrich, St. Louis, MO, USA,) and acidic
polysaccharides such as glycosaminoglycans in cartilage
with Alcian blue (Sigma-Aldrich), respectively.
For microscopic imaging, 4*105 cells were transferred
into a sterile dish with a cover glass bottom (0.17-mm
thick) and incubated for 1 day until they attached to the
glass surface. Cell monolayers were used. The cells were
imaged before the induction of differentiation (day 0)
and on days 7, 14, and 21 of osteogenic and chondro-
genic differentiation. Untreated cells served as controls
and were imaged on the same days of culturing. The
cells were washed twice using phosphate-buffered saline,
and then placed in FluoroBrite™ DMEM (Gibco, Carlsbad,
CA, USA) with 10% FBS and 0.58 mg/ml L-glutamine
(PanEco) and 40 U/ml gentamicin.
Multiphoton fluorescence microscopy and FLIM
The two-photon excited fluorescence intensity and FLIM
images of NAD(P)H and FAD were obtained using an
LSM 710 (Carl Zeiss, Oberkochen, Germany) inverted
laser scanning confocal microscope equipped with a time-
correlated single photon counting (TCSPC) system (Sim-
ple-Tau 152, Becker & Hickl GmbH, Berlin, Germany).
NAD(P)H and FAD fluorescence was excited with a
Chameleon Vision II (Coherent, Santa Clara, CA, USA)
Ti:Sa femtosecond laser, using an 80 MHz repetition rate
and a pulse duration of 140 fs at wavelengths of 750 nm and
900 nm, respectively. Emission was detected in the ranges
455–500 nm for NAD(P)H, and 500–550 nm for FAD.
An average of 8000–10,000 photons was collected per
decay curve. The absence of photobleaching was con-
firmed by the constant photon count rate during image
acquisition.
The average power of the Ti:Sa laser was measured
using a PM100A power meter (ThorLabs Inc., Newton,
NJ, USA). An internal microscope reference, reporting the
two-photon excitation efficiency, was used to control the
laser power in all the experiments. The average power in-
cident on the samples was approximately 6 mW.
A C-Apochromat 40x/1.2 water immersion objective
was used for image acquisition.
The presence of collagen fibers was confirmed by Second
Harmonic Generation (SHG) microscopy. SHG of collagen
was excited at a wavelength of 750 nm and detected in the
range 373–387 nm.
During the experiments the cells were maintained at
37 °C and 5% CO2 in an XL multi S Dark LS incubator
(PeCon GmbH, Erbach, Germany).
Optical redox ratio calculation
The optical redox ratio was defined as the fluorescence
intensity of FAD divided by the fluorescence intensity of
NAD(P)H. The redox ratio was calculated from corre-
sponding two-photon fluorescence images of FAD and
NAD(P)H after subtracting the background on a pixel
by pixel basis using ImageJ 1.39p software (NIH,
Bethesda, MD, USA).
Fluorescence lifetime analysis
The fluorescence lifetimes and their contributions (free
and protein-bound forms of NAD(P)H and FAD: t1-free
NADH, t2-bound NAD(P)H, a1-free NADH, a2-bound
NAD(P)H; t1-bound FAD, t2-free FAD, a1-bound FAD,
a2-free FAD) for the regions of interest (ROIs) were cal-
culated by finding the global minimum of the χ2 value.
The mean values of χ2 and the fluorescence lifetimes in
undifferentiated MSCs and in MSCs during differenti-
ation were assessed in the cell cytoplasm. Bi-exponential
fitting was used for the analysis of both cofactors. FLIM
images were processed in SPCImage software (Becker &
Hickl GmbH).
Statistical analysis
For each time point of the differentiation activity, from 23
to 78 randomly selected cells and from 47 to 120 ROIs
were inspected. A statistical analysis was performed using
STATISTICA 64 software, version 10 (StatSoft Inc., Tulsa,
OK, USA). Mean and standard deviation (SD) values were
used to express the data. Differences in the mean values
were tested for significance using the Student’s t test or
the one-way ANOVA with Fisher’s post hoc test (p ≤ 0.05).
Results
Osteogenic and chondrogenic differentiation of MSCs
Immunophenotypic profile of human bone marrow
MSCs was characterized by identification of common
markers. Isolated MSCs were uniformly positive for
CD105, CD90, CD73, CD44, CD54, and negative for
CD34, CD45, HLA-DR (Table 1).
MSC differentiation was identified by cellular morph-
ology and specific staining. Before differentiation the
MSCs had a spindle-shaped morphology and the cell
Table 1 Fluorescence-activated cell sorting analysis of MSCs
Cell marker Marker availability, %
CD34 (sialomucin) 1.290 ± 0.001
CD44 (hyaluronic acid receptor) 90.050 ± 0.006
CD45 (leukocyte common antigen) 0.460 ± 0.001
CD73 (5′-terminal nucleotidase) 93.030 ± 0.040
CD90 (Thy-1) 98.880 ± 0.001
CD54 (intercellular adhesion molecule 1) 47.830 ± 0.014
CD105 (endoglin) 97.130 ± 0.002
HLA-DR (major histocompatibility complex II) 1.600 ± 0.001
The data are expressed as mean ± SD. n = 3
MSCs mesenchymal stem cells
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population was homogeneous. By day 21 the differenti-
ated cells had become polygonal in morphology. Alizarin
Red S staining of the cells on day 21 of osteogenic differ-
entiation showed dense extracellular matrix calcification.
Alcian blue staining of the cells on day 21 of chondro-
genic differentiation showed the presence of glycosami-
noglycans (Fig. 1). The cells not incubated in osteogenic
and chondrogenic media retained their spindle-shaped
morphology through to day 21 and did not show any
specific staining with the corresponding dyes.
Using SHG microscopy we showed the presence of
collagen fibers in chondrogenically differentiating cells at
all time points of differentiation (7, 14, 21 days). In the
case of osteogenic differentiation, collagen fibers were
detected only on day 21 of differentiation. In undifferen-
tiated cells collagen was not detected at all time points
of examination (Fig. 2).
Optical redox ratio during MSC differentiation
To estimate the rate of metabolic activity of the cells dur-
ing osteogenic and chondrogenic differentiation, the fluor-
escence intensities of NAD(P)H and FAD were measured
and represented as the redox ratio (FAD/NAD(P)H).
Representative dynamics of the ratios in differentiating
MSCs are shown in Fig. 3a. The analysis of fluorescence
intensities of NAD(P)H and FAD showed that during
both differentiations FAD makes the main contribution
to the redox ratio changes (Fig. 3b). NAD(P)H fluores-
cence intensity did not change in chondrogenic differen-
tiation, and slightly increased on day 14 in osteogenic
differentiation.
In the early stage of osteogenic and chondrogenic
differentiation (day 7) a significant increase in the redox
ratio was detected (0.83 ± 0.16 and 0.85 ± 0.15 vs 0.57 ±
0.12; p <0.000000). Subsequently the redox ratio gradually
decreased in both cases, and by day 21 was lower than in
the undifferentiated control cells (0.57 ± 0.13 and 0.65 ±
0.11 vs 0.77 ± 0.13; p <0.000000) (Fig. 3c). In both differen-
tiations the redox ratios were significantly different
between all days of differentiation within each group
(p = 0.000002, p = 0.000005, p = 0.000000 for osteo-
genic, p = 0.003557, p = 0.000006, p = 0.000000 for chon-
drogenic differentiations). In the undifferentiated control
statistically significant differences were detected between 7
and 14, 7 and 21 days.
FLIM of NAD(P)H during differentiation
Since NADH is involved mostly in bioenergy release, we
analyzed the fluorescence lifetimes and lifetime contri-
butions of the free and protein-bound forms of NADH
as indicators of the energy metabolism in the MSCs. It is
known, that a bias toward oxidative metabolism results
in a higher lifetime value and a higher contribution from
protein-bound NADH [16–18].
As NAD(P)H fluorescence combines the contributions
from free NADH, bound NADH and bound NADPH
[19], and NADPH can be involved in oxidative stress,
often associated with stem cell differentiation [20], as a
preliminary, we tested the applicability of the three-
exponential model for the fit of the fluorescence decay
curves in order to estimate the contribution of NADPH
to the overall fluorescence of NAD(P)H. This model was
developed for separating NADH and NADPH by Blacker
et al. [21]. However, the use of the three-exponential fit
did not improve χ2 (0.8–1.2) when compared with the
bi-exponential fit, and displayed an insignificant number
of areas with a fluorescence lifetime t3 = 4.4 ns, corre-
sponding to NADPH (approximately 1–3% of the total
area of the images) at any differentiation stage. This
allowed us to conclude, that the contribution of NADPH
is negligible, and that bi-exponential fitting is rational
for the analysis of the FLIM data.
It was found that, for osteogenic differentiation on day
7, the fluorescence lifetimes of the free (t1) and bound
(t2) forms of NAD(P)H were lower than in the undiffer-
entiated control. Further observation revealed a small,
but statistically significant, increase of the short and long
lifetimes of NAD(P)H (Fig. 4a, b) in differentiating cells.
Fig. 1 Microscopic images of undifferentiated and differentiated MSCs in transmitted light. a Undifferentiated MSCs, incubated in standard growth
medium b MSCs on day 21 of osteogenic differentiation (Alizarin Red S staining) c MSCs on day 21 of chondrogenic differentiation (Alcian blue staining).
The image size is 1289 × 964 μm (1392 × 1041 pixels)
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Fig. 2 Overlapped two-photon excited autofluorescence (green) and SHG (red) images of undifferentiated MSCs, and MSCs during osteogenic
and chondrogenic differentiation on day 21. The image size is 130 × 130 μm (512 × 512 pixels). MSCs mesenchymal stem cells
Fig. 3 Redox ratio of FAD/NAD(P)H in differentiating MSCs. a Fluorescence and optical redox images of undifferentiated MSCs and MSCs during
osteogenic and chondrogenic differentiation. Fluorescence of FAD is shown in green, fluorescence of NAD(P)H in blue. b Dynamics of the
fluorescence intensity of NAD(P)H and FAD in undifferentiated MSCs and MSCs during osteogenic and chondrogenic differentiation, mean ± SD.
*Statistically significant difference on NAD(P)H with undifferentiated MSCs on the same day; #statistically significant difference on FAD with
undifferentiated MSCs on the same day c Dynamics of the ratio in undifferentiated MSCs and MSCs during osteogenic and chondrogenic
differentiation, mean ± SD. *Statistically significant difference with undifferentiated MSCs on the same day. For NAD(P)H: excitation - 750 nm,
detection - 455–500 nm; for FAD: excitation - 900 nm, detection - 500–550 nm. The image size is 213 × 213 μm (1024 × 1024 pixels). FAD oxidized
form of flavin adenine dinucleotide, MSCs mesenchymal stem cells, NAD(P)H reduced nicotinamide adenine dinucleotide (phosphate)
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The fluorescence lifetime contribution of protein-
bound NAD(P)H (a2) was higher than in the undifferen-
tiated MSCs at all time points during the differentiation,
indicating, in general, a more oxidative state. The max-
imum elevation of bound NAD(P)H was detected in
MSCs on 7 day of differentiation, which, along with an
increased redox ratio at this time point, indicates a
metabolic switch toward a more oxidative status com-
pared with that of the undifferentiated cells. Subse-
quently, the contribution of protein-bound NAD(P)H in
osteogenically differentiated MSCs gradually decreased
(Fig. 4b), probably due to a bias toward more glycolytic
metabolism.
In the case of chondrogenic differentiation, the fluor-
escence lifetime of the free (t1) form of NAD(P)H only
increased on day 7. The fluorescence lifetime of bound
NAD(P)H (t2) did not change until day 21, when it
slightly decreased (Fig. 5a, b).
The contribution of bound NAD(P)H (a2) in differ-
entiating cells was less than in the non-differentiating
ones throughout the observations, showing their more
glycolytic status. In the process of differentiation the
a2 value gradually decreased, with a statistically sig-
nificant difference from the control at all differenti-
ation stages, pointing to a shift toward glycolysis
(Fig. 5b).
Therefore, along with decreasing redox ratios, these
results suggest a shift to a more glycolytic metabolism in
both types of differentiation.
FLIM of FAD during differentiation
Although FAD plays an essential role in mitochondrial
respiration, it is also involved in a number of other cellular
pathways, including biosynthetic processes, and these are
pronounced in differentiating stem cells. It was therefore
hard to predict whether its behavior would correlate with
the trajectories in energy metabolism or not.
During osteogenic differentiation the fluorescence
lifetimes of free (t2) and protein-bound (t1) FAD were
lower on day 7 than in the undifferentiated MSCs, but
they then increased, exceeding the corresponding con-
trol values on days 14 and 21 of differentiation.
The fluorescence lifetime contribution of bound FAD
(a1) was lower at all time points compared with the
undifferentiated cells. However, the a1 value increased
(insignificantly) in osteogenically differentiated MSCs
from day 7 to day 21 (Fig. 6a, b).
In chondrogenic differentiation the fluorescence life-
times of FAD did not change appreciably. The only small
difference (decrease) from the undifferentiated cells was
detected on day 21.
A statistically significant increase in the protein-bound
FAD contribution (a1) (in comparison with the undiffer-
entiated MSCs, which showed no changes from day 7 to
day 21) was revealed during chondrogenic differentiation
(Fig. 7a, b).
Therefore, the parameters of the FAD fluorescence
lifetimes did not agree with our observations related
to energy metabolism. In the case of osteogenic
Fig. 4 FLIM of NAD(P)H in MSCs during osteogenic differentiation. a Pseudocolor-coded images of the free (t1) and protein-bound (t2)
forms of NAD(P)H. Field of view 213*213 μm (512*512 pixels). b Dynamics of the fluorescence lifetimes of free and protein-bound forms
of NAD(P)H and fluorescence lifetime contributions of the protein-bound forms of NAD(P)H in MSCs. Mean ± SD. *Statistically significant
difference with undifferentiated MSCs on the same day. P values are shown. MSCs mesenchymal stem cells, NAD(P)H reduced nicotinamide adenine
dinucleotide (phosphate)
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differentiation with a marked oxidative state of the
MSCs at all stages, the bound FAD fluorescence life-
time and contribution were reduced. On the contrary,
during chondrogenic differentiation in MSCs having a
more glycolytic state, the bound FAD fluorescence
lifetime and contribution increased. Taken together,
these data suggest that a separate FAD-involving
pathway is activated.
Discussion
The FLIM technique implemented on the TCSPC
principle is a powerful tool for stem cell biology. In this
study we investigated the metabolic changes in living
MSCs during osteogenic and chondrogenic differenti-
ation, using two-photon fluorescence microscopy and
FLIM. Based on the data for the FAD/NAD(P)H redox
ratio and on the fluorescence lifetimes of protein-bound
Fig. 5 FLIM of NAD(P)H in MSCs during chondrogenic differentiation. a Pseudocolor-coded images of the free (t1) and protein-bound (t2) forms
of NAD(P)H. Field of view 213*213 μm (512*512 pixels). b Dynamics of the fluorescence lifetimes of free and protein-bound forms of NAD(P)H
and fluorescence lifetime contributions of the protein-bound forms of NAD(P)H in MSCs. Mean ± SD. *Statistically significant difference with
undifferentiated MSCs on the same day. P values are shown. MSCs mesenchymal stem cells, NAD(P)H reduced nicotinamide adenine
dinucleotide (phosphate)
Fig. 6 FLIM of FAD in MSCs during osteogenic differentiation. a Pseudocolor-coded images of the protein-bound (t1) and free (t2) forms of FAD.
Field of view 213*213 μm (512*512 pixels). b Dynamics of the fluorescence lifetimes of free and protein-bound forms of FAD and fluorescence
lifetime contributions of the protein-bound forms of FAD in MSCs. Mean ± SD. *Statistically significant difference with undifferentiated MSCs on
the same day. P values are shown. FAD oxidized form of flavin adenine dinucleotide, MSCs mesenchymal stem cells
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NAD(P)H, we registered a metabolic shift toward a more
glycolytic status in the process of MSC differentiation.
The difference was that, in osteogenic differentiation, an
increase in oxidative phosphorylation preceded the shift
to the glycolytic status in the process of such MSC
differentiation. The fluorescence lifetime characteristics
of FAD indicated the stimulation of an unknown meta-
bolic pathway, where protein-bound FAD participates.
An increasing body of evidence has appeared that
oxidative metabolism and the upregulation of mitochon-
drial function are essential for the successful differenti-
ation of MSCs [22, 23].
We detected an increased redox ratio of FAD/NAD(P)H
and an increased contribution of protein-bound NADH at
the beginning of osteogenic differentiation (day 7) that
verifies an elevation of the OxPhos rate. Active OxPhos is
likely required to meet the high ATP demands needed for
the extensive biosynthesis of extracellular matrix protein
during osteogenesis. Chen et al. reported the activation of
OxPhos in MSCs during osteogenic differentiation [24]. In
a recent study, Guntur et al. performed bioenergetic
profiling during osteogenic differentiation of calvarial
osteoblasts, and also observed activation of OxPhos [25].
In other studies, where no changes in the OxPhos rates
were detected in osteogenically differentiating MSCs
[14, 26], this may be associated with the use of culture
media containing pyruvate, as this can feed directly into
the mitochondrial citric acid cycle. However, Shum et al.
showed that while OxPhos is activated during MSC osteo-
genesis, glycolytic activity does not decrease [13]. The
authors reported that OxPhos becomes active only at the
stage of osteogenic differentiation when proliferation is
less pronounced, and this is in agreement with our data.
Moreover Long’s group suggested a continuous depend-
ence on glycolysis during osteogenic differentiation [26].
In chondrogenic differentiation we observed a decreasing
FAD/NAD(P)H redox ratio and a decreasing contribution
of protein-bound NADH, which enabled us to suggest that
differentiated cells (chondrocytes) rely predominantly on
glycolysis, although the use of oxidative phosphorylation
cannot be excluded. Indeed, the production of lactate
normally seen under normoxia, referred to as the Warburg
effect, has previously been demonstrated for chondrocytes
that reside under hypoxia in vivo [27, 28]. Wang et al. also
reported higher rates of glycolysis following chondrogenic
differentiation when compared to proliferative MSCs [29].
In the study by Pattappa et al. co-determination of azide-
sensitive oxygen consumption and glycolysis indicated that
chondrogenic cultures utilize oxidative phosphorylation
for, at most, 13% of their total ATP production on day 21,
thereby resulting in a predominantly glycolytic metabolism
(89%) [14]. However, the authors associated the suppressed
oxidative phosphorylation with the culture conditions
rather than with the chondrogenic state per se.
The underlying mechanism of a metabolic shift to
glycolytic status during osteogenic and chondrogenic
differentiation may be related to enhanced collagen syn-
thesis that requires a more reduced state of the cells. For
example, increased lactate production has been associ-
ated with collagen deposition by fibroblasts during
wound healing [30] and by MSCs during osteoblastic
differentiation. In the study by Ghukasyan et al. [31] col-
lagen deposition was detected on day 21 after the
addition of osteoblastic induction factors. However, the
organization of collagen into larger bundles was signifi-
cantly greater only by day 28. In our study using SHG
Fig. 7 FLIM of FAD in MSCs during chondrogenic differentiation. a Pseudocolor-coded images of the protein-bound (t1) and free (t2) forms of
FAD. Field of view 213*213 μm (512*512 pixels). b Dynamics of the fluorescence lifetimes of free and protein-bound forms of FAD and fluorescence
lifetime contributions of the protein-bound forms of FAD in MSCs. mean ± SD. *Statistically significant difference with undifferentiated MSCs on the
same day. P values are shown. FAD oxidized form of flavin adenine dinucleotide, MSCs mesenchymal stem cells
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microscopy we showed the presence of collagen fibers in
chondrogenically differentiating cells at all time points
of differentiation (7, 14, 21 days). In case of osteogenic
differentiation, collagen fibers were detected only on day
21 of differentiation.
While energy metabolism involving NAD(P)H is quite
well described for stem cells using the FLIM method
[16, 32, 33], the dynamics of FAD lifetimes during stem
cell differentiation have been very poorly investigated.
The problem with FAD, in this context, is that it is
involved in many other metabolic pathways besides
energy metabolism, which complicates interpretation of
the results. Previously, we had detected a decreased
contribution of protein-bound FAD during adipogenic
differentiation of MSCs against the background of a shift
toward more oxidative metabolism [18, 34], which is
likely associated with the beta-oxidation of fatty acids,
where FAD is reduced to FADH2. If no other pathways
contribute much to the state of the FAD, the decreased
lifetime contribution of bound FAD is associated with a
greater emphasis on glycolytic metabolism, as was
shown by Skala et al. for epithelial precancer [35].
In our study we detected an elevated contribution of
protein-bound FAD when, presumably, the glycolysis
rate was increased (chondrogenic differentiation) and
a reduced contribution where there was initially more
oxidative metabolism, and a subsequent increase dur-
ing a shift toward a greater emphasis on glycolysis
(osteogenic differentiation). We speculate that the in-
consistency of the parameters of energy metabolism and
FAD may be connected with the involvement of FAD in
the alpha-ketoglutarate dehydrogenase complex. One of
the reactions of the TCA cycle occurring outside the mito-
chondria is the cleavage of alpha-ketoglutarate to succinate
and carbon dioxide. This reaction is involved in the hy-
droxylation of the prolyl and lysyl residues of protocolla-
gen, a step in the synthesis of collagen. It is possible that
increase of the fluorescence intensity of FAD during MSCs
differentiation was due to participation of FAD in this
biosynthetic pathway.
However, the dynamics of the free and bound forms of
FAD during stem cell differentiation require further
appropriate metabolic measurements.
Currently, multiphoton microscopy is applied for in
vivo tracking of stem cells labelled with fluorescent pro-
tein [36]. Label-free two-photon FLIM of metabolic co-
factors is a promising strategy for analysis of stem cell
behavior in living animals. Although FLIM technique
has been successfully used on stem cell cultures [37],
three-dimensional models of spheroids [38] and scaf-
folds [39], and on tissue slices [40], its capabilities
have been poorly explored in stem cell research in
vivo so far. The possibility of using FLIM for analysis
of the relationship between metabolic oscillations and
circadian phase within epidermal stem cells in live
mice at the single-cell level has been demonstrated
recently in the study by Stringari et al. [41]. The re-
sults of our study provide a basis for label-free moni-
toring of stem cell differentiation in vivo with the use
of two-photon FLIM of metabolic status.
Conclusions
In this study, probing of the metabolic status of MSCs
during osteogenic and chondrogenic differentiation was
implemented for the first time with the use of optical
metabolic imaging of the two cofactors - NAD(P)H and
FAD. Our data suggest that biosynthetic processes,
associated, presumably, with the synthesis of collagen,
drive energy metabolism in differentiating cells, and pro-
mote a metabolic shift from a more oxidative to a more
glycolytic state. Understanding of the metabolic peculiar-
ities of stem cells and the changes accompanying the
differentiation process is extremely important for the
development of new treatment strategies in regenerative
medicine and stem cell therapy.
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